AGN.WT
AGN.WT

Algernon Pharmaceuticals Inc. - Warrants

Associated Securities:
Status
Delisted
Issued & Outstanding24,401,300
Reserved for Issuance0
Currency
CSE Index

About

Algernon Pharmaceuticals Inc. - Warrants

Listing date
November 04, 2019

Algernon Pharmaceuticals is a clinical stage pharmaceutical development company focused on advancing its lead compounds for non–alcoholic steatohepatitis (NASH), chronic kidney disease (CKD) inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough.

Algernon Pharmaceuticals Inc. - Common Shares